Overexpression, purification, enzymatic and microscopic characterization of recombinant mycobacterial F-ATP synthase

被引:7
作者
Saw, Wuan-Geok [1 ]
Wong, Chui-Fann [1 ]
Dick, Thomas [2 ,3 ]
Gruber, Gerhard [1 ]
机构
[1] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore
[2] Hackensack Meridian Hlth, Ctr Discovery & Innovat, Nutley, NJ USA
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore
基金
新加坡国家研究基金会;
关键词
F-ATP synthase; Bioenergetics; Tuberculosis; Mycobacterium; Drug discovery; Electron microscopy; SUBUNIT EPSILON; EXPRESSION; INHIBITORS; MODEL;
D O I
10.1016/j.bbrc.2019.11.098
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The F-ATP synthase is an essential enzyme in mycobacteria, including the pathogenic Mycobacterium tuberculosis. Several new compounds in the TB-drug pipeline target the F-ATP synthase. In light of the importance and pharmacological attractiveness of this novel antibiotic target, tools have to be developed to generate a recombinant mycobacterial F1Fo ATP synthase to achieve atomic insight and mutants for mechanistic and regulatory understanding as well as structure-based drug design. Here, we report the first genetically engineered, purified and enzymatically active recombinant M. smegmatis F1Fo ATP synthase. The projected 2D- and 3D structures of the recombinant enzyme derived from negatively stained electron micrographs are presented. Furthermore, the first 2D projections from cryo-electron images are revealed, paving the way for an atomic resolution structure determination. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:374 / 380
页数:7
相关论文
共 35 条
  • [1] LL-37 enhances adaptive antitumor immune response in a murine model when genetically fused with M-CSFRJ6-1 DNA vaccine
    An, LL
    Yang, YH
    Ma, XT
    Lin, YM
    Li, G
    Song, YH
    Wu, KF
    [J]. LEUKEMIA RESEARCH, 2005, 29 (05) : 535 - 543
  • [2] A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
    Andries, K
    Verhasselt, P
    Guillemont, J
    Göhlmann, HWH
    Neefs, JM
    Winkler, H
    Van Gestel, J
    Timmerman, P
    Zhu, M
    Lee, E
    Williams, P
    de Chaffoy, D
    Huitric, E
    Hoffner, S
    Cambau, E
    Truffot-Pernot, C
    Lounis, N
    Jarlier, V
    [J]. SCIENCE, 2005, 307 (5707) : 223 - 227
  • [3] [Anonymous], 2010, Multidrug and extensively drug-resistant TB(M/XDR-TB): 2010 Global Report on Surveillance and Response
  • [4] Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery
    Bald, Dirk
    Villellas, Cristina
    Lu, Ping
    Koul, Anil
    [J]. MBIO, 2017, 8 (02):
  • [5] Expression, purification and crystallization of native and selenomethionine labeled Mycobacterium tuberculosis FGD1 (Rv0407) using a Mycobacterium smegmatis expression system
    Bashiri, Ghader
    Squire, Christopher J.
    Baker, Edward N.
    Moreland, Nicole J.
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 2007, 54 (01) : 38 - 44
  • [6] Metabolic Engineering of Cofactor F420 Production in Mycobacterium smegmatis
    Bashiri, Ghader
    Rehan, Aisyah M.
    Greenwood, David R.
    Dickson, James M. J.
    Baker, Edward N.
    [J]. PLOS ONE, 2010, 5 (12):
  • [7] Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon
    Bhat, Zubair Shanib
    Rather, Muzafar Ahmad
    Maqbool, Mubashir
    Ahmad, Zahoor
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2018, 103 : 1733 - 1747
  • [8] Variations of Subunit ε of the Mycobacterium tuberculosis F1Fo ATP Synthase and a Novel Model for Mechanism of Action of the Tuberculosis Drug TMC207
    Biukovic, Goran
    Basak, Sandip
    Manimekalai, Malathy Sony Subramanian
    Rishikesan, Sankaranarayanan
    Roessle, Manfred
    Dick, Thomas
    Rao, Srinivasa P. S.
    Hunke, Cornelia
    Grueber, Gerhard
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (01) : 168 - 176
  • [9] Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline
    Blaser, Adrian
    Sutherland, Hamish S.
    Tong, Amy S. T.
    Choi, Peter J.
    Conole, Daniel
    Franzblau, Scott G.
    Cooper, Christopher B.
    Upton, Anna M.
    Lotlikar, Manisha
    Denny, William A.
    Palmer, Brian D.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (07) : 1283 - 1291
  • [10] Energetics of Pathogenic Bacteria and Opportunities for Drug Development
    Cook, Gregory M.
    Greening, Chris
    Hards, Kiel
    Berney, Michael
    [J]. ADVANCES IN MICROBIAL PHYSIOLOGY, VOL 65: ADVANCES IN BACTERIAL PATHOGEN BIOLOGY, 2014, 65 : 1 - 62